http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021098750-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2021-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb8e707516f01f270307e892288a945f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de913d5efe5afb801d9b4d965d43fba |
| publicationDate | 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021098750-A |
| titleOfInvention | MDM2 inhibitor dosing regimen to treat cancer |
| abstract | PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for treating cancer in a subject in need of treatment for cancer, particularly a subject having liposarcoma having the MDM2 gene. MDM2 inhibitors ((3'R, 4'S, 5'R) -N-[(3R, 6S) -6-carbamoyltetrahydro-2H-pyran-3) specific to the subject according to a specific dosing regimen. -Il] -6 "-chloro-4'-(2-chloro-3-fluoropyridin-4-yl) -4,4-dimethyl-2" -oxo-1 ", 2" -dihydrodispyro [cyclohexane- Treat cancer according to methods and treatment regimens for treating cancer in subjects in need thereof, including administration of 1,2'-pyrrolidine-3', 3 "-indole] -5'-carboxamide). Provided are a pharmaceutical composition for use in particular. [Selection diagram] None |
| priorityDate | 2015-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.